IMUX

IMU-838 (vidofludimus calcium) | CALVID-1

COVID-19

Phase 2 (Top-line Data)

Exp Date

H2 2020

Amp Volatility Score

Catalyst Info & Data Links

TITLE: IMU-838 (vidofludimus calcium) in COVID-19 - Phase 2 Top-line Data

  • ClinicalTrial.gov (NCT04379271): A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)


  • ClinicalTrial.gov (NCT04516915): IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC)


WHAT IS THE CATALYST EVENT?


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • H2 2020


PRIOR DATA

PRESS RELEASES

MECHANISM OF ACTION / RATIONALE

  • IMU-838 is a small molecule investigational drug (vidofludimus calcium) under development as an oral tablet formulation for the treatment of relapsing-remitting multiple sclerosis, or RRMS, inflammatory bowel disease, or IBD, and other chronic inflammatory and autoimmune diseases. The company is also investigating IMU-838 as a potential treatment option for coronavirus disease 2019, or COVID-19.

  • By inhibiting dihydroorotate dehydrogenase (DHODH), a key enzyme of pyrimidine de novo biosynthesis, metabolically activated T and B immune cells experience metabolic stress, and the release of Th1 and Th17 key cytokines including IL-17A, IL-17F and IFNg is inhibited, thereby reducing inflammation. In preclinical studies of vidofludimus, the active moiety and free acid form of IMU-838, apoptosis (or programmed cell death) was induced in activated T cells, which Immunic believes may also play a crucial role in the activity of the drug by further dampening the inflammatory response (Learn more). 

Updated by HC

#IMUX, #IMU-838, #vidofludimus_calcium, #CALVID-1, #COVID

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon